INTRODUCTION
============

Polynucleotide kinases (Pnk) comprise a widely distributed family of nucleic acid repair enzymes that heal broken RNA or DNA ends by converting 5′-OH termini into 5′-PO~4~ ends that can be sealed by RNA or DNA ligases. The founding member of this family is bacteriophage T4 polynucleotide kinase-phosphatase (T4 Pnkp), a bifunctional enzyme with 5′-OH kinase and 3′-phosphatase activities that collaborates with T4 RNA ligase 1 to repair tRNA damage inflicted during the *Escherichia coli* antiviral response ([@gkt936-B1]). Whereas *E. coli* has no endogenous RNA end-healing enzymes, many other bacteria do. For example, the Pnkp•Hen1 RNA repair system is encoded in an operon present in diverse bacteria from many phyla ([@gkt936-B2]). Bacterial Pnkp is the end-healing and end-sealing component and comprises three catalytic domains: N-terminal kinase, central phosphatase and C-terminal ligase ([@gkt936-B2],[@gkt936-B6]). The kinase domain catalyzes phosphoryl transfer to the 5′-OH RNA end. The phosphatase domain releases P~i~ from 2′-PO~4~, 3′-PO~4~ or 2′,3′-cyclic-PO~4~ ribonucleotides ([@gkt936-B9]). The ligase domain, in a 1:1 complex with the N-terminal half of the Hen1 protein, is an ATP-dependent RNA sealing enzyme ([@gkt936-B13]). The C-terminal half of Hen1 is a Mn^2+^-dependent methyltransferase that installs a 2′-OCH~3~ mark at the RNA repair junction before ligation and thereby protects the junction from recurrent damage ([@gkt936-B3],[@gkt936-B4],[@gkt936-B14],[@gkt936-B15]).

The N-terminal 170-amino acid segment of *Clostridium thermocellum* (*Cth*) Pnkp is an autonomous polynucleotide kinase (Pnk) domain. *Cth*Pnk phosphorylates 5′-OH single-stranded RNA or DNA using ATP, GTP, CTP, UTP or dATP as the phosphate donor ([@gkt936-B16]). The enzyme also catalyzes the reverse reaction, in which a polynucleotide 5′-PO~4~ group is transferred to ADP, GDP, CDP, UDP or dADP to form the corresponding NTP ([@gkt936-B16]). *Cth*Pnk requires a divalent cation cofactor; this requirement is satisfied by magnesium, manganese or cobalt ([@gkt936-B2]).

Initial crystal structures of *Cth*Pnk bound to ATP•Mg^2+^ and ADP•Mg^2+^, reflective of substrate and product nucleotide complexes, respectively, showed that *Cth*Pnk is a homodimer and a member of the P-loop phosphotransferase superfamily ([@gkt936-B6]). *Cth*Pnk shares with phage T4 Pnk a core phosphotransferase fold (a central 4-strand parallel β sheet flanked by α helices) ([@gkt936-B17],[@gkt936-B18]), but is embellished by a distinctive homodimerization module composed of secondary structure elements that have no counterparts in T4 Pnk.

The ATP phosphate donor binds to *Cth*Pnk within a crescent-shaped groove formed by the P-loop (^15^GSSGSGKST^23^) and an overlying 'lid' composed of helices α6 and α7 and the connecting ^120^RTDRQVE^126^ peptide. The ATP α and β phosphates are engaged by a network of hydrogen bonds from Thr23 and the P-loop main-chain amides; the γ phosphate is anchored by the lid residues Arg120 and Arg123 and the P-loop Ser17. The P-loop lysine (Lys21) and the catalytic Mg^2+^ bridge the ATP β and γ phosphates. The P-loop serine (Ser22) is the sole enzymic constituent of the octahedral metal coordination complex, which also includes nonbridging β and γ phosphate oxygens of ATP and three waters. Mutational analysis by alanine scanning underscored the essentiality of P-loop residues Lys21 and Ser22 in the NTP donor site ([@gkt936-B6]). The lid residues Arg120 and Arg123 provide important, but functionally redundant, contacts to the γ phosphate oxygens ([@gkt936-B16]). Based on the structural and mutational data, we proposed a catalytic mechanism whereby Lys21 and Mg^2+^ stabilize the transition state on the ATP γ phosphorus, assisted by the lid arginines ([@gkt936-B6],[@gkt936-B16]).

Subsequent crystal structures of *Cth*Pnk in complexes with GTP, CTP, UTP and dATP phosphate donors ([@gkt936-B16]) revealed the principles of nucleobase nonspecific NTP substrate utilization, whereby the kinase establishes an identical network of ionic and hydrogen-bonding contacts to the α, β and γ phosphates of whichever NTP donor is bound, while the interactions of the nucleoside moiety are limited to a π-cation stack of the nucleobase on the Arg116 side chain in helix α6 of the lid.

Having explored the architecture of the NTP donor site, we aimed here to define the structural basis for engagement of the phosphoacceptor strand and the mechanism by which the polynucleotide 5′-OH nucleophile is oriented and activated for its attack on the NTP γ phosphorus. To that end, we have co-crystallized *Cth*Pnk mutant D38N with GTP•Mg^2+^ and a 5′-OH oligonucleotide and with GDP•Mg^2+^ and a 5′-PO~4~ oligonucleotide and determined the atomic structures of the Michaelis complex and product complex.

MATERIALS AND METHODS
=====================

*Cth*Pnk purification and mutagenesis
-------------------------------------

The pET28b-Smt3*Cth*Pnkp-(1--170) expression plasmid encoding the Pnk domain was described previously ([@gkt936-B6]). Alanine mutations were introduced into the expression vector by the two-stage polymerase chain reaction (PCR)-based overlap extension method. The Pnk inserts were sequenced to confirm the presence of the desired mutation and the absence of unwanted coding changes. The plasmids were transformed into *E. coli* BL21(DE3). Recombinant protein production was induced with IPTG and the *Cth*Pnk proteins were purified as described ([@gkt936-B16]). In brief, the His~10~Smt3-*Cth*Pnk proteins were recovered from soluble bacterial lysates by Ni-agarose chromatography. The tag was removed by treatment with Smt3 protease Ulp1 and the tag-free *Cth*Pnk was separated from the cleaved His~10~Smt3 tag by a second round of Ni-agarose chromatography. The *Cth*Pnk preparations were then adjusted to 10 mM EDTA, concentrated by centrifugal ultrafiltration, and gel-filtered through a column of Superdex-200 equilibrated in 50 mM Tris--HCl, pH 7.5, 100 mM NaCl, 10% glycerol, 1 mM DTT, 1 mM EDTA. The enzyme preparations were stored at −80°C. Protein concentrations were determined by using the BioRad dye reagent with bovine serum albumin as the standard.

Kinase assay
------------

Reaction mixtures (10 μl) containing 50 mM Tris--HCl (pH 7.0), 10 mM MgCl~2~, 5 mM DTT, 100 μM \[γ^32^P\]ATP, 100 pmol of a 10-mer 5′-OH DNA oligonucleotide phosphoacceptor (~HO~CCTGTATGAT) and wild-type or mutant kinase as specified were incubated for 30 min at 45°C. The reactions were quenched by adding an equal volume of 90% formamide, 50 mM EDTA and 0.01% bromophenol blue/xylene cyanol, and the mixtures were analyzed by electrophoresis (at 7 W constant power) through a 15-cm 20% polyacrylamide gel containing 8 M urea in 45 mM Tris borate, 1.2 mM EDTA. The ^32^P-labeled DNAs were visualized and quantified by scanning the gel with a Fuji Film BAS-2500 imager.

Crystallization, diffraction data collection and structure determination
------------------------------------------------------------------------

A D38N mutation was introduced into the pET28b-His~10~Smt3-*Cth*Pnk-L137M expression vector by the two-stage PCR-based overlap extension method. The tag-free *Cth*Pnk-D38N protein was purified as described ([@gkt936-B6],[@gkt936-B16]). The protein solution (10.5 mg/ml) was adjusted to either 2 mM GTP, 10 mM MgCl~2~ and 1.1 mM 5′-OH oligonucleotide (~HO~CCTGT) or 2 mM GDP, 10 mM MgCl~2~ and 1.1 mM 5′-PO~4~ oligonucleotide (pCCTGT) and incubated for 10 min before aliquots of the protein solution (2 µl) were mixed on a coverslip with an equal volume of precipitant solution containing 100 mM sodium citrate, pH 5.0, 100 mM MgCl~2~, 18--24% (v/v) PEG-6000. Crystals were grown at 22°C by hanging drop vapor diffusion against a reservoir of the same precipitant solution. Single crystals were transferred to a solution containing 100 mM sodium citrate, pH 5.0, 2 mM GTP/GDP, 100 mM MgCl~2~, 18--24% PEG-6000, 1.1 mM 5′-OH/5′-PO~4~ oligonucleotide and 15% glycerol before freezing the crystals in liquid nitrogen. Diffraction data were collected at NSLS beamline X25 equipped with a Pilatus 6M detector in 370 continuous increments of 0.5° each for the Michaelis complex and in 440 continuous increments of 0.2° each for the product complex. The data were integrated and reduced with MOSFLM and SCALA. Diffraction statistics are compiled in [Table 1](#gkt936-T1){ref-type="table"}. The crystals were in space group P2~1~2~1~2~1~ and had two *Cth*Pnk protomers per asymmetric unit. To solve the structure of the Michaelis complex with 5′-OH oligonucleotide, phases were obtained via molecular replacement in PHASER using a search model constructed by removing waters from the *Cth*Pnk•GTP•Mg^2+^ dimer structure reported previously ([@gkt936-B16]). Following the placement of the dimer by PHASER and rigid body refinement, the active sites of both protomers revealed clear and continuous F~o~--F~c~ density for the 5′-OH oligonucleotide. To determine the structure of the product complex with GDP, Mg^2+^ and 5′-PO~4~ oligonucleotide, the diffraction data were refined against the model of the Michaelis complex, from which the GTP γ-phosphates and the 5′-OH oligonucleotides had been removed. The 5′-PO~4~ oligonucleotides were then modeled into the F~o~--F~c~ maps of the active site. The models were iteratively rebuilt by hand in COOT ([@gkt936-B25]) and refined in PHENIX ([@gkt936-B26]). The final models had excellent geometry, no Ramachandran outliers, and no large F~o~--F~c~ difference Fourier peaks ([Table 1](#gkt936-T1){ref-type="table"}). Table 1.Crystallographic data and refinement statistics*Cth*Pnk•GTP•Mg^2+^•~HO~DNA*Cth*Pnk•GDP•Mg^2+^•pDNASpace groupP2~1~2~1~2~1~P2~1~2~1~2~1~Unit cell dimensions (Å) @ 130 Ka = 53.0a = 54.4b = 72.8b = 73.1c = 119.5c = 119.0Diffraction data quality    Resolution (Å)53.0--1.73 (1.76--1.73)46.2--1.8 (1.9--1.8)    Radiation sourceNSLS X25NSLS X25    Wavelength1.10 Å1.10 Å    Processing softwareMosflm/ScalaMosflm/Scala    R~sym~[^a^](#gkt936-TF1){ref-type="table-fn"}, %8.4 (38.7)4.5 (19.8)    Unique reflections49 311 (2645)43 723 (6304)    Mean redundancy11.9 (7.4)3.0 (3.0)    Completeness, %100.0 (99.2)97.8 (97.6)    Mean *I/σI*20.1 (4.7)13.6 (4.7)Phasing statistics    Phasing methodPhenix AutoMR    Resolution (Å)53.0--2.0    Signal to noise[^b^](#gkt936-TF2){ref-type="table-fn"}RFZ = 27.6, TFZ = 38.2Refinement and model statistics (*F* \> 0)    Resolution (Å)48.5--1.73 (1.75--1.73)41.0--1.8 (1.82--1.80)    Completeness, %99.5 (97.2)97.3 (98.0)    *R*~free~[^c^](#gkt936-TF3){ref-type="table-fn"}/*R*~work~, %19.6/16.3 (27.7/22.3)20.6/16.4 (27.1/22.3)    RMSD bonds/angles0.006 Å/1.13°0.006 Å/1.09°    Protomers/ASU22    Ramachandran plot99.4% favored, no outliers99.1% favored, no outliers B-factors, Å^2^        Overall/Wilson21.3/17.821.8/20.0    PDB ID4MDF4MDEModel contents    Protein residues342342    Heteroatoms2 GTP, 2 Mg^2+^, 1 citrate, 2 oligonucleotides2 GDP, 2 Mg^2+^, 2 oligonucleotides    Water395440[^1][^2][^3][^4]

RESULTS AND DISCUSSION
======================

Strategy for crystallizing a Michaelis complex of *Cth*Pnk
----------------------------------------------------------

Bacterial, bacteriophage and baculovirus Pnk enzymes implicated in RNA repair all share a conserved motif Asp-X-X-Arg (^38^DFCR^41^ in *Cth*Pnk; ^35^DDYR^38^ in T4 Pnk) located downstream of the P-loop in the primary structure ([@gkt936-B6],[@gkt936-B19],[@gkt936-B20]). Mutational analysis of T4 Pnkp had identified the Asp35 and Arg38 side chains as essential for catalysis ([@gkt936-B21],[@gkt936-B22]). The initial crystal structure of the T4 Pnkp kinase domain homodimer implicated Arg38 in binding the terminal phosphodiester of the ~HO~NpN-- acceptor strand, as surmised from its bidentate coordination of a sulfate anion in the acceptor site ([@gkt936-B17]). The essential Asp35 side chain was proposed to coordinate the 5′-OH and activate its attack on the NTP γ phosphorus ([@gkt936-B17]). Consistent with the proposed general base mechanism, replacing Asp35 with Asn abolished T4 Pnkp kinase activity ([@gkt936-B21]). However, other investigators invoked a role for Asp35 in binding a magnesium ion ([@gkt936-B18]). Subsequent crystal structures obtained by soaking short oligonucleotides into preformed T4 Pnkp crystals revealed that Asp35 does indeed coordinate the 5′-OH and that Arg38 contacts the first phosphodiester ([@gkt936-B23]). However, none of the available T4 Pnk structures have a metal cofactor in the kinase active site and none have an NTP substrate in the phosphate donor site.

The missing link in the RNA-repairing Pnk saga is a structure of the Michaelis complex containing NTP donor, metal cofactor and 5′-OH polynucleotide acceptor. Capturing this state along the reaction pathway requires that phosphoryl transfer reaction chemistry be precluded, e.g. by a minimally perturbing modification of the enzyme or the substrates. Our mutational analysis of *Cth*Pnk had shown that the Asp38 and Arg41 residues in the putative acceptor site are essential for kinase activity ([@gkt936-B6]). We reasoned that replacing Asp38 with asparagine might arrest the kinase reaction as a stable Michaelis complex without compromising substrate binding. Hence, we grew crystals of *Cth*Pnk-D38N in the presence of GTP, Mg^2+^ and oligonucleotide ~HO~CpCpTpGpT. The crystals diffracted X-rays to 1.73 Å, were in space group P2~1~2~1~2~1~ and had two protomers per asymmetric unit organized as a kinase homodimer. The electron density maps revealed occupancy of the acceptor sites of both protomers by oligonucleotide. The refinement statistics and model contents of the *Cth*Pnk•GTP•Mg^2+^•~HO~DNA structure are provided in [Table 1](#gkt936-T1){ref-type="table"}. Unless specified otherwise, the images and descriptions of the Michaelis complex refer to the A protomer.

Overview of the structure
-------------------------

A semitransparent surface view of the *Cth*Pnk protomer is shown in [Figure 1](#gkt936-F1){ref-type="fig"} (left panel) with stick models of GTP in the phosphate donor site and of the 5′-OH oligonucleotide in the phosphoacceptor site. A single Mg^2+^ ion (magenta sphere) is present in the donor site, where it bridges the GTP β and γ phosphates. The F~o~--F~c~ electron density in the acceptor site (shown in stereo in [Figure 2](#gkt936-F2){ref-type="fig"}A) permitted modeling of the first four nucleotides ~HO~C^1^pC^2^pT^3^pG^4^p of the pentanucleotide ligand used for co-crystallization. All four nucleobases adopt an *anti* nucleoside conformation. The first two nucleotides of the 5′-OH acceptor strand bind in a deep groove on the enzyme surface so as to place the terminal 5′-OH group next to the GTP γ phosphate ([Figure 1](#gkt936-F1){ref-type="fig"}, left panel). The sequential nucleobases are splayed out in different directions from the phosphodiester backbone, i.e. there is no base stacking. The C^1^ and C^2^ nucleobases are sandwiched between protein surfaces that comprise the deep groove. The T^3^ and G^4^ nucleobases each pack on one face against an exposed surface of the kinase ([Figure 1](#gkt936-F1){ref-type="fig"}, right panel). The opposite faces of T^3^ and G^4^ are solvent exposed. The structure indicates that the 5′-OH end of the oligonucleotide phosphoacceptor must be single-stranded to access the kinase active site. Figure 1.Surface views of the Michaelis complex. The left panel shows a semitransparent surface view of *Cth*Pnk with stick models of the GTP phosphate donor (at left) and the oligonucleotide phosphoacceptor strand (at right). A Mg^2+^ ion (magenta sphere) bridges the GTP β and γ phosphates. The 5′-OH of the acceptor strand is adjacent to the GTP γ phosphate. The right panel shows a close-up view of the first four nucleotides of the phosphoacceptor strand, highlighting the splayed out trajectories of the consecutive nucleobases and their packing against the enzyme surface. Figure 2.The phosphoacceptor binding site. (**A**) Stereo view of the F~o~--F~c~ electron density map (colored red) of the 5′-OH oligonucleotide contoured at 3.0 σ. The component nucleotides are shown as stick models with gray carbons. The 2F~o~--F~c~ density for the Asn38 side chain is colored gray and contoured at 1.5 σ. (**B**) Stereo view of the architecture of the phosphoacceptor site and pertinent atomic contacts. The kinase fold is depicted with cyan helices and magenta strands. Selected amino acids are shown as stick models with beige carbons. The oligonucleotide is rendered as a stick model with green carbons. Electrostatic and hydrogen bonding interactions are denoted by black dashed lines. Van der Waals contacts and π stacking interactions are denoted by beige dashed lines.

The phosphoacceptor binding site
--------------------------------

A stereo view of the atomic contacts of the ~HO~C^1^pC^2^pT^3^pG^4^p acceptor strand is shown in [Figure 2](#gkt936-F2){ref-type="fig"}B. Electrostatic and hydrogen-bonding interactions are denoted by black dashed lines; van der Waals contacts are depicted as beige dashed lines. The first phosphodiester ~HO~C^1^pC^2^ of the acceptor strand is fixed in place by a network of contacts with three of the phosphodiester oxygens. The terminal guanidinium nitrogens of the essential Arg41 residue make bidentate contacts with the nonbridging OP2 and bridging O5′ atoms of the first phosphodiester. The OP2 atom receives an additional hydrogen bond from Ser37-Oγ. The nonbridging OP1 oxygen is coordinated by hydrogen bonds from Thr80-Oγ and the Thr80 main-chain amide nitrogen. The second phosphodiester C^2^pT^3^ receives a hydrogen bond to a nonbridging oxygen from Gln83-Nε. The third phosphodiester T^3^pG^4^ accepts a hydrogen bond to a nonbridging oxygen from the Tyr128 hydroxyl group.

The kinase engages each of the four nucleobases via interactions with aliphatic and/or aromatic side chains. Val129 and Gln51 sandwich the first pyrimidine base (C^1^). Val129 sits above the C^1^ base in the view shown in [Figure 2](#gkt936-F2){ref-type="fig"}B and makes van der Waals contacts from Cγ1 (3.5 Å) and Cγ2 (3.9 Å) to the cytosine C2 and C4 atoms, respectively. Gln51 makes van der Waals contacts to the underside of the C^1^ base, from Cγ (3.8 Å), Cδ (3.6 Å) and Oε (3.9 Å) to the cytosine C5, C6 and N1 atoms, respectively. Phe58 makes a π stack on the second pyrimidine base (C2). Thr54 makes van der Waals contacts from Cγ (3.7 Å) and Cβ (3.9 Å) to the C7 and C5 atoms, respectively, of the third pyrimidine base (T^3^). Tyr128 makes a π stack on the fourth purine base (G^4^) and a van der Waals contact of the phenolic oxygen (3.6 Å) to the guanosine sugar O4′ atom. These interactions are nonspecific with respect to the identity of the nucleobase. The C1 base does make two hydrophilic interactions via the base edge: (i) an intramolecular hydrogen bond from N4 to a nonbridging oxygen of the third phosphodiester, and (ii) accepting a hydrogen bond to O2 from His133-Nε.

Active site of the Michaelis complex: geometry and general base catalysis
-------------------------------------------------------------------------

A detailed stereo view of the active site is shown in [Figure 3](#gkt936-F3){ref-type="fig"}A, which highlights the orientation and pertinent atomic contacts of GTP and the first two nucleotides ~HO~C^1^pC^2^ of the acceptor strand. GTP and Mg^2+^ occupy the same positions in the Michaelis complex as in the kinase•GTP•Mg^2+^ donor complex reported previously ([@gkt936-B16]). The guanine nucleobase makes a π-cation stack over Arg116. Lys21 makes a bifurcated ionic interaction with the GTP β and γ phosphates. The GTP γ phosphate is engaged by P-loop residue Ser17 and by lid residues Arg120 and Arg123. The octahedral coordination complex of the Mg^2+^ ion includes Ser22-Oγ, three waters and two nonbridging β and γ phosphate oxygen atoms (those not engaged by Lys21). Figure 3.Active sites of the Michaelis complex and product complex. Stereo views of the Michaelis complex (**A**) and product complex (**B**). The kinase fold is depicted with cyan helices and magenta strands. Selected amino acids are shown as stick models with beige carbons. The guanine nucleotides and oligonucleotides are rendered as stick models with green carbons. Mg^2+^ is a magenta sphere; waters in the metal coordination complex are red spheres. Electrostatic and hydrogen bonding interactions are denoted by black dashed lines. The magenta dashed line indicates the path of the O5′ nucleophile of the acceptor strand toward the GTP γ phosphorus.

The O5′ nucleophile of the acceptor strand is situated 3.0 Å from the GTP γ phosphorus atom (see the magenta dashed line in [Figures 3](#gkt936-F3){ref-type="fig"}A and [4](#gkt936-F4){ref-type="fig"}A) and is almost perfectly apical to the bridging β phosphate oxygen of the GDP leaving group (O5′--P--O angle = 168°). Asn38-Nδ coordinates the 5′-OH (2.8 Å). We surmise that the kinase is 'all revved up with no place to go' because Asp38 is the essential general base catalyst that abstracts a proton from the 5′-OH and activates the nucleophile for attack on the NTP donor. Orientation of the aspartate general base is aided by atomic contacts of Oδ1 to Arg41 and of Oδ2 (Nδ in the structure) with a water in the metal coordination complex ([Figure 3](#gkt936-F3){ref-type="fig"}A). The position and conformation of the Asn38 side chain in the Michaelis complex mimics that of the native Asp38 side chain seen in the structure of the wild-type *Cth*Pnk•GTP•Mg^2+^ donor complex ([@gkt936-B16]). Although the electron density does not discriminate Asn38 Nδ from Oδ, our assignment of the orientation of the amide group is consistent with the 2.8 Å distance from Arg41-NH1 to a terminal atom of the Asn38 amide, whereby Arg41-NH1 donates a hydrogen bond to Asn38-Oδ. The reverse orientation of Asn38 would not favor this close contact, insofar as the Nδ atom is not the preferred hydrogen bond acceptor. Figure 4.Michaelis complex and product complex structures illuminate the mechanism and stereochemistry of the Pnk reaction. The guanine nucleotide, Mg^2+^ and oligonucleotide moieties of the superimposed Michaelis complex (**A**) and product complex (**B**) are shown, indicative of the states immediately before and following the phosphoryl transfer reaction. For illustrative purposes, Asn38 was changed to the native Asp38 by substituting a red oxygen atom for Nδ. Atomic contacts of the Lys21, Arg41 and Asp38 residues are indicated by dashed lines. (A) Attack of the oligonucleotide O5′ nucleophile on the NTP γ phosphorus is depicted by the blue arrow. The bridging β-γ oxygen of the GTP substrate (denote by the asterisk) is the leaving group and is situated apical to the O5′ nucleophile. (B) The transferred phosphate has undergone stereochemical inversion. The GDP β phosphate OP3 atom (denoted by asterisk), which was the leaving atom in the forward kinase reaction, is poised to act as the attacking nucleophile in the 'reverse kinase' reaction. Lys21 and Mg^2+^ stabilize the putative phosphorane transition state of the γ phosphate during the forward kinase reaction and of the 5′-PO~4~ during the reverse reaction. Asp38 is a proposed general base catalyst of the forward kinase reaction and a general acid catalyst of the reverse reaction.

[Figure 4](#gkt936-F4){ref-type="fig"}A shows a stripped-down model of the Michaelis complex in which the Asn38 side chain is changed back to the native aspartate. This image shows only the enzymic functional groups Lys21, Asp38 and Arg41 that are essential per se for catalysis, as judged by the ablation of activity when they are replaced by alanine. The model summarizes the key features of the proposed chemical mechanism of the kinase reaction: (i) Lys21 and Mg^2+^ stabilize an associative phosphorane transition state on the NTP γ phosphate; (ii) Arg41 positions the 5′-OH acceptor strand proximal to the NTP γ phosphate; and (iii) Asp38 orients and activates the O5′ nucleophile by general base catalysis.

Capturing a product complex of *Cth*Pnk with GDP•Mg^2+^ and 5′-PO~4~ strand
---------------------------------------------------------------------------

We grew co-crystals of *Cth*Pnk-D38N with GDP•Mg^2+^ and a 5′-PO~4~-terminated oligonucleotide, pCpCpTpGpT and solved the structure at 1.8 Å resolution ([Table 1](#gkt936-T1){ref-type="table"}). All five nucleotides of the DNA strand were modeled into F~o~--F~c~ electron density ([Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt936/-/DC1)). A detailed stereo view of the product complex is shown in [Figure 3](#gkt936-F3){ref-type="fig"}B, while [Figure 4](#gkt936-F4){ref-type="fig"}B shows a stripped-down model of the product complex in which the Asn38 side chain is changed back to the native aspartate. In the product complex, the GDP β phosphate and oligonucleotide 5′-PO~4~ are 2.5 Å apart at their closest point and are bridged by Lys21 (2.7 Å) and the Mg^2+^ ion ([Figure 4](#gkt936-F4){ref-type="fig"}B), which ameliorate the electrostatic repulsion of the adjacent β phosphate and 5′ phosphate groups. Asn38-Nδ (i.e. Asp38 in the native kinase) coordinates the 5′-bridging oxygen of the terminal phosphate (3.0 Å) ([Figure 4](#gkt936-F4){ref-type="fig"}B). We surmise that this structure captures the forward kinase reaction in the state immediately following phosphoryl transfer. Note that the 5′-PO~4~ has undergone stereochemical inversion in the product complex compared with the GTP γ phosphate in the substrate complex, consistent with an in-line mechanism ([@gkt936-B24]). Moreover, it is clear that the GDP β phosphate O3 atom of the product complex (denoted by the asterisk in [Figure 4](#gkt936-F4){ref-type="fig"}B) corresponds to the bridging oxygen-leaving group of the Michaelis complex (asterisk in [Figure 4](#gkt936-F4){ref-type="fig"}A). The product complex can be viewed as synonymous with the Michaelis complex of the 'reverse kinase' reaction. This inference is supported by the proximity of the GDP β phosphate O3 atom (the putative nucleophile in the reverse kinase reaction; denoted by the asterisk in [Figure 4](#gkt936-F4){ref-type="fig"}B) to the 5′ phosphorus of the oligonucleotide (3.3 Å) and its near apical orientation with respect to the 5′-bridging phosphate oxygen (O--P--O5′ angle = 146°). In this state, the D38N mutant kinase is arrested in place because it lacks the Asp38 general acid that donates a proton to the O5′ leaving group.

In the product complex, Arg120 coordinates the GDP β phosphate. Ser17 and Arg123 engage the oligonucleotide 5′-PO~4~ ([Figure 3](#gkt936-F3){ref-type="fig"}B). Otherwise, the trajectory and enzymic contacts of the first four nucleotides of the 5′-PO~4~ strand are virtually identical to those observed for the 5′-OH strand in the forward Michaelis complex. The fifth thymidine nucleotide in the product complex makes no atomic contacts with the kinase protomer to which it is bound (though the T^5^ nucleosides do make lattice contacts with kinase protomers in neighboring asymmetric units).

Mutational analysis of the phosphoacceptor site
-----------------------------------------------

To gauge the contributions of selected amino acids identified by the structure as constituents of the phosphoacceptor site, we mutated Ser37, Phe58, Thr80, Gln83, Tyr128 and His133 to alanine. The wild-type and mutant *Cth*Pnk proteins were produced in *E. coli* and purified as described previously ([@gkt936-B16]). Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of the preparations verified that they were similarly pure with respect to the 19 kDa *Cth*Pnk polypeptide ([Figure 5](#gkt936-F5){ref-type="fig"}A). We assayed the extent of label transfer from 100 µM \[γ^32^P\]ATP to 10 µM 10-mer ~HO~DNA acceptor as a function of input protein ([Figure 5](#gkt936-F5){ref-type="fig"}B). (The nucleobase sequence of the 5′ half of the acceptor substrate was identical to that of the ligand used for co-crystallization of the Michaelis complex.) Specific activities of the wild-type and mutant kinases were derived by linear regression curve fitting in Prism and are plotted in bar graph format in [Figure 5](#gkt936-F5){ref-type="fig"}C. Mutational effects fell into three categories. Alanine substitutions for Gln83 and Tyr128 were benign, i.e. the specific activities of the Q83A and Y128A kinases were 98 and 82% of the wild-type value. Alanines in lieu of Ser37, Thr80 or His133 elicited moderate decrements in specific activity: to 33, 28 and 26% of wild-type, respectively. Replacing Phe58 with alanine was singularly deleterious, the specific activity of the F58A mutant being only 8% of the wild-type value ([Figure 5](#gkt936-F5){ref-type="fig"}C). Thus, of the individual phosphoacceptor contacts probed here by alanine scanning, the π-π interaction of Phe58 with the penultimate nucleobase appears to be the most important for kinase function. Figure 5.Structure-guided mutagenesis of the phosphoacceptor site. (**A**) Aliquots (3 µg) of the *Cth*Pnk-(1--170) proteins were analyzed by SDS-PAGE. The polypeptides were visualized by staining with Coomassie blue dye. The positions and sizes (kDa) of marker polypeptides are indicated. (**B**) Kinase reactions were performed as described in 'Materials and Methods' section. The reaction mixtures included 100 μM \[γ^32^P\]ATP, 100 pmol of a 10-mer 5′-OH DNA oligonucleotide phosphoacceptor (~HO~CCTGTATGAT) and wild-type or mutant kinase as indicated. The extents of DNA phosphorylation are plotted as a function of input protein. Each datum is the average of three titration experiments ± SEM. (**C**) Specific activities of the wild-type and mutant kinases derived by linear regression curve fitting in Prism. The error bars indicate the standard deviation of the curve fit.

Comparison of phosphoacceptor binding modes in *Cth*Pnk versus T4 Pnk
---------------------------------------------------------------------

Eastberg et al. ([@gkt936-B23]) obtained structures of T4 Pnk with short 5′-OH DNAs in the kinase acceptor site by soaking two different 5-mer oligonucleotides (~HO~GTCAC and ~HO~TGCAC) into preformed kinase crystals. In both cases (pdb 1RC8 and 1RPZ), only the first three nucleotides of the acceptor strand could be modeled into electron density. The positions and contacts of the terminal ~HO~Np nucleotide are conserved in the two T4 Pnk structures, but the path and contacts of the second and third nucleotides are different ([Figure 6](#gkt936-F6){ref-type="fig"}, compare middle and lower panels) ([@gkt936-B23]). To query shared and distinctive aspects of acceptor recognition by the bacterial and phage kinases, we aligned the acceptor sites of the two T4 Pnk•DNA structures to that of the *Cth*Pnk Michaelis complex ([Figure 6](#gkt936-F6){ref-type="fig"}). That the variant Asn38 side chain in the *Cth*Pnk Michaelis complex coordinates the oligonucleotide O5′ in the same manner as does the Asp35 side chain in the T4 Pnk•oligo complexes supports our contention that Asn38 faithfully mimics the atomic interactions of the native Asp38 residue, with Asp38 and Asp35 acting as general base catalysts for *Cth*Pnk and T4 Pnk, respectively. Other conserved features of acceptor recognition include (i) anchoring of the first phosphodiester by arginine and threonine side chains (Arg41/Thr80 in *Cth*Pnk; Arg38/Thr86 in T4 Pnk); (ii) a salt bridge between Asp38/Asp35 and the essential Arg41/Arg38 side chain that orients the general base; and (iii) packing of the first nucleobase against aliphatic side chains that line the acceptor pocket (Val129/His133 in *Cth*Pnk; Val135/Met139 in T4 Pnk). The position of the terminal ~HO~Np nucleotide is almost identical in the bacterial and phage Pnk acceptor sites, notwithstanding that the nucleobases are different (cytosine in *Cth*Pnk versus guanine or thymine in the T4 Pnk structures). A notable distinction between the interactions of the two kinases with the terminal ~HO~Np nucleotide is that the contact of *Cth*Pnkp Ser37 with the first phosphodiester (loss of which impacts kinase activity) is not conserved in T4 Pnk. Rather, the corresponding Arg34 side chain in T4 Pnk either (i) coordinates the second phosphodiester of the ~HO~GpTpC ligand (P2 in [Figure 6](#gkt936-F6){ref-type="fig"}, middle panel) or (ii) makes a cation-π stack over the C8-N7 edge of the penultimate guanine nucleobase of the ~HO~TpGpC ligand (G^2^ in [Figure 6](#gkt936-F6){ref-type="fig"}, bottom panel) while also engaging in a bonding network with Glu57 and Thr61. Figure 6.Comparison of acceptor binding modes in *Cth*Pnk versus T4 Pnk. Stereo views of the aligned and vertically offset phosphoacceptor binding sites of *Cth*Pnk bound to oligonucleotide ~HO~CCTG (from the B protomer; *top panel*), T4 Pnk bound to oligonucleotide ~HO~GTC (from pdb 1RC8; *middle panel*) and T4 Pnk bound to oligonucleotide ~HO~TCG (from pdb 1RPZ; *bottom panel*). The oligonucleotides are depicted as stick models with green carbons. Amino acid carbons are colored beige (*top panel*), blue (*middle panel*) or cyan (*bottom panel*). Atomic contacts are indicated by black dashed lines.

The structural alignment highlights extreme divergence of the *Cth*Pnk and T4 Pnk acceptor sites starting from the second nucleotide of the acceptor strand. From the perspective of the nucleic acid substrate, the salient difference is that there is no stacking of consecutive nucleobases in the *Cth*Pnk structure. By contrast, both T4 Pnkp•DNA structures reveal acceptor base stacking, albeit different patterns of stacking according to the sequence of the acceptor strand. In the ~HO~GpTpC complex, the G^1^ and T^2^ bases stack on one another while the C^3^ base is splayed out almost orthogonal to the first two bases ([Figure 6](#gkt936-F6){ref-type="fig"}, middle panel). In the ~HO~TpGpC complex, the G^2^ base projects in the opposite direction and stacks over the C^3^ base ([Figure 6](#gkt936-F6){ref-type="fig"}, bottom panel). The G^2^ base in T4 Pnkp•~HO~TpGpC adopts a position analogous to the C^2^ base of the *Cth*Pnk Michaelis complex, but the enzymic interactions of the base differ: to wit, the G^2^ base in T4 Pnk stacks on the Arg34-Glu57 ion pair ([Figure 6](#gkt936-F6){ref-type="fig"}, bottom panel), while the C^2^ base in *Cth*Pnk makes a π stack on Phe58 ([Figure 6](#gkt936-F6){ref-type="fig"}, top panel). *Cth*Pnkp Phe58 occupies the same space as the Arg34 guanidinium moiety in T4 Pnkp•~HO~TpGpC. The T4 Pnk residue corresponding to *Cth*Pnk Phe58 is Thr61, which either (i) makes van der Waals contacts with the C^3^ base in the ~HO~GpTpC complex ([Figure 6](#gkt936-F6){ref-type="fig"}, middle panel), or (ii) donates a hydrogen bond to the G^2^ base in the ~HO~TpGpC complex ([Figure 6](#gkt936-F6){ref-type="fig"}, bottom panel).

The Gln83 position in *Cth*Pnkp that donates a hydrogen bond to the second phosphodiester of the acceptor strand is occupied by a shorter Asn89 side chain in T4 Pnkp. Asn89 makes van der Waals contacts to the second phosphodiester in the ~HO~GpTpC complex and a van der Waals contact to the C^3^ base in the ~HO~TpGpC complex. Although neither of the T4 Pnkp•DNA structures has a modeled fourth nucleobase akin to G^4^ in *Cth*Pnk, the positions of the third ribose are such that the trajectory of the fourth nucleoside will be different than what we see in *Cth*Pnk, where G4 stacks on Tyr128. (The T4 Pnkp equivalent of Tyr128 is Asp134.)

In summary, the conservation of the terminal ~HO~Np site in the T4 and *Cth* kinases attests to the shared catalytic mechanism via fixation of the first phosphodiester and deployment of an aspartate general base. The acceptor sites of these two enzymes are otherwise distinct, with respect to the path of the acceptor strand and the enzymic functional groups that interact with the single strand nucleic acid.
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###### Supplementary Data

[^1]: Standard definitions are used for all parameters. Figures in parentheses refer to data in the highest resolution bin. The refinement and geometric statistics come from PHENIX.

[^2]: ^a^*R*~sym~ output as as *R*~merge~ by SCALA.

[^3]: ^b^Signal to noise ratios for final translation function Z-score (TFZ) and rotation function Z-score (RFZ) as output by PHASER for *Cth*Pnk•GTP•Mg^2+^•~HO~DNA data set.

[^4]: ^c^*R*~free~ sets consisted of 8% of data chosen at random against which structures were not refined.
